Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | MPO | P05164 | 1/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | CLK1 | P49759 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14603341 | 0.75 | PARP15 (0.55) | CSNK2A1KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL11932491 | 0.75 | CSNK2A1 (0.45) | CSNK2A1GAA | |
| SCHEMBL21964140 | 0.74 | MPO (0.60) | NPSR1MPOKDM4EHTTALDH1A1 | |
| SCHEMBL28351989 | 0.74 | GPR3 (0.58) | NPSR1MPOKDM4EHTTALDH1A1 | |
| SCHEMBL10169211 | 0.74 | GPR3 (0.57) | NPSR1MPOCSNK2A1KDM4EHTT | |
| SCHEMBL9283331 | 0.74 | NPSR1 (0.60) | NPSR1MPOKDM4EHTTALDH1A1 | |
| SCHEMBL1634728 | 0.71 | NPSR1 (0.57) | NPSR1MPOKDM4EHTTALDH1A1 | |
| SCHEMBL1634865 | 0.71 | MPO (0.60) | NPSR1MPOKDM4EHTTALDH1A1 | |
| SCHEMBL14603356 | 0.71 | PARP15 (0.51) | NPSR1CSNK2A1KDM4EHTTALDH1A1 | |
| SCHEMBL30736043 | 0.71 | NPSR1 (0.57) | NPSR1MPOKDM4EHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | Life Technologies Corporation | 2015-09-03 | — | — | US | disclosed |
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | Life Technologies Corporation | 2015-09-03 | — | — | US | disclosed |
| US-20140356873-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | LIFE TECHNOLOGIES CORP (US) | 2014-12-04 | — | — | US | disclosed |
| US-20140356873-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | LIFE TECHNOLOGIES CORP (US) | 2014-12-04 | — | — | US | disclosed |
| US-8846925-B2 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings | Life Technologies Corporation (US) | 2014-09-30 | — | — | US | disclosed |
| US-8846925-B2 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings | Life Technologies Corporation (US) | 2014-09-30 | — | — | US | disclosed |
| US-20120315661-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | Life Technologies Corporation (US) | 2012-12-13 | — | — | US | disclosed |
| US-8183375-B2 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings | Life Technologies Corporation (US) | 2012-05-22 | — | — | US | disclosed |
| US-8183375-B2 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings | Life Technologies Corporation (US) | 2012-05-22 | — | — | US | disclosed |
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | Life Technologies Corporation (US) | 2011-02-03 | — | — | US | disclosed |
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | Life Technologies Corporation (US) | 2011-02-03 | — | — | US | disclosed |
| US-7816519-B2 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | Life Technologies Corporation (US) | 2010-10-19 | — | — | US | disclosed |
| US-7816519-B2 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | Life Technologies Corporation (US) | 2010-10-19 | — | — | US | disclosed |
| EP-1311487-B1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | MOLECULAR PROBES INC (US) | 2008-11-26 | — | — | EP | disclosed |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | INVITROGEN CORPORATION (US) | 2007-04-26 | — | — | US | disclosed |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | INVITROGEN CORPORATION (US) | 2007-04-26 | — | — | US | disclosed |
| US-7169922-B2 | Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond | INVITROGEN CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
| US-7169922-B2 | Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond | INVITROGEN CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | CYP3A7, UGT1A7, UGT2B7 | NPSR1 1137/4885MPO 3018/4885CSNK2A1 3938/4885 |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | CYP3A4, CYP3A5, UGT1A4 | NPSR1 888/4885MPO 2691/4885CSNK2A1 4341/4885 |
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | CYP3A7, UGT1A7, UGT2B7 | NPSR1 1137/4885MPO 3018/4885CSNK2A1 3938/4885 |
| US-20140356873-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | CYP3A7, UGT1A7, UGT2B7 | NPSR1 1137/4885MPO 3018/4885CSNK2A1 3938/4885 |
| US-20120315661-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | CYP3A7, UGT1A7, UGT2B7 | NPSR1 1137/4885MPO 3018/4885CSNK2A1 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.